000			01449 a2200385 4500
005			20250517033210.0
264		0	_c20160415
008			201604s 0 0 eng d
022			_a2159-3345
024	7		_a10.1089/nat.2014.0529 _2doi
040			_aNLM _beng _cNLM
100	1		_aLi, Weibin
245	0	0	_aAptamer Oligonucleotides: Novel Potential Therapeutic Agents in Autoimmune Disease. _h[electronic resource]
260			_bNucleic acid therapeutics _cAug 2015
300			_a173-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650	0	4	_aAptamers, Nucleotide _xchemical synthesis
650	0	4	_aArthritis, Rheumatoid _xdrug therapy
650	0	4	_aAutoimmunity _xdrug effects
650	0	4	_aDNA, Single-Stranded _xchemistry
650	0	4	_aDiabetes Mellitus _xdrug therapy
650	0	4	_aDrug Stability
650	0	4	_aHumans
650	0	4	_aHydrogen Bonding
650	0	4	_aImmunologic Factors _xchemical synthesis
650	0	4	_aLupus Erythematosus, Systemic _xdrug therapy
650	0	4	_aMolecular Targeted Therapy
650	0	4	_aMultiple Sclerosis _xdrug therapy
650	0	4	_aMyasthenia Gravis _xdrug therapy
650	0	4	_aSELEX Aptamer Technique
650	0	4	_aStatic Electricity
700	1		_aLan, Xiaopeng
773	0		_tNucleic acid therapeutics _gvol. 25 _gno. 4 _gp. 173-9
856	4	0	_uhttps://doi.org/10.1089/nat.2014.0529 _zAvailable from publisher's website
999			_c24919474 _d24919474